» Articles » PMID: 28399391

CD163-Positive Macrophages Within the Tumor Stroma Are Associated With Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma

Overview
Date 2017 Apr 12
PMID 28399391
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Increasing evidence shows that tumor stromal components, particularly tumor-associated macrophages (TAMs), play an important role in the tumor progression of various solid malignant tumor types. However, their roles in oral squamous cell carcinoma (OSCC) have not been fully elucidated.

Materials And Methods: Seventy human tongue OSCC samples were analyzed in the present study. Immunohistochemistry was used to investigate the correlations between the densities of CD68-, CD163-, and CD204-positive TAMs and clinicopathologic parameters. Lymphatic vessel density (LVD) was estimated using the D2-40 antibody. In vitro studies also were conducted to investigate the effect of conditioned medium (CM) derived from OSCC cell lines on cytokine and chemokine expression in RAW264.7 mouse monocytic leukemia cells.

Results: Increased densities of CD68-, CD163-, and CD204-positive TAMs were significantly correlated with lymph node metastasis (P = .035, .0082, and .038, respectively). Higher LVD occurred considerably more frequently in patients with nodal metastasis than in those without such metastasis. Moreover, LVD was considerably increased in patients with higher CD163-positive TAM densities. Studies using immunofluorescence showed that vascular endothelial growth factor (VEGF)-C was expressed in 52 of 70 patients with CD163-positive TAMs (74.2%). Moreover, CM derived from OSCC cell lines stimulated the expression of Il-10, Ccl22, Vegf-a, and Vegf-c in RAW264.7 cells; however, Il-12p35 expression levels were not changed.

Conclusion: CD163-positive TAMs promote lymphangiogenesis through VEGF-C expression, which contributes to regional lymph node metastasis in OSCC.

Citing Articles

Exploring the function of myeloid cells in promoting metastasis in head and neck cancer.

Okwuone D, Morgan D, Gan G Explor Target Antitumor Ther. 2024; 5(1):108-119.

PMID: 38468824 PMC: 10925485. DOI: 10.37349/etat.2024.00208.


The Three-Dimensional In Vitro Cell Culture Models in the Study of Oral Cancer Immune Microenvironment.

Abdolahinia E, Han X Cancers (Basel). 2023; 15(17).

PMID: 37686542 PMC: 10487272. DOI: 10.3390/cancers15174266.


Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy.

Lee Y, Hsu C, Chen Y, Ou D, Hsu C, Tan C Cancer Immunol Res. 2023; 11(11):1553-1567.

PMID: 37669022 PMC: 10618654. DOI: 10.1158/2326-6066.CIR-23-0133.


Diagnostic, Prognostic, and Therapeutic Role for Angiogenesis Markers in Head and Neck Squamous Cell Carcinoma: A Narrative Review.

Alessandrini L, Astolfi L, Daloiso A, Sbaraglia M, Mondello T, Zanoletti E Int J Mol Sci. 2023; 24(13).

PMID: 37445908 PMC: 10341715. DOI: 10.3390/ijms241310733.


Prognostic Role of CD68 and CD163 Tumour-Associated Macrophages and PD-L1 Expression in Oral Squamous Cell Carcinoma: A Meta-Analysis.

Chohan M, Perry M, Laurance-Young P, Salih V, Foey A Br J Biomed Sci. 2023; 80:11065.

PMID: 37397243 PMC: 10310926. DOI: 10.3389/bjbs.2023.11065.